Jacobs Levy Equity Management, Inc Leap Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.35 - $4.01 $69,813 - $207,373	-51,714 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$1.48 - $1.92 $671,853 - $871,593	-453,955 Reduced 89.77%	51,714 $85,000
Q1 2021 May 17, 2021	BUY	$1.82 - $3.01 $505,583 - $836,156	277,793 Added 121.91%	505,669 $961,000
Q4 2020 Feb 16, 2021	BUY	$1.49 - $2.37 $8,183 - $13,016	5,492 Added 2.47%	227,876 $513,000
Q3 2020 Nov 16, 2020	BUY	$1.68 - $2.17 $373,605 - $482,573	222,384 New	222,384 $440,000

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $344M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.